---
title: IMAX Corporation Reports Third Quarter Results
publisher: "IMAX"
description: "HIGHLIGHTS -- The Matrix Revolutions: The IMAX Experience breaks box office records, grossing over $3 million in 48 IMAX(R) theatres in North America in its first five days. -- Net losses of $0.07 per share consistent with guidance. Company expects to earn $0.10 to $0.15 for all of 2003 before a"
canonical: "https://www.imax.com/pr/imax-corporation-reports-third-quarter-results-2"
date: 2003-11-10
last_updated: 2003-11-12
---

IMAX Corporation Reports Third Quarter Results
==============================================

Mon, Nov 10, 2003

     HIGHLIGHTS

     -- The Matrix Revolutions: The IMAX Experience breaks box office
        records, grossing over $3 million in 48 IMAX(R) theatres in North
        America in its first five days.

     -- Net losses of $0.07 per share consistent with guidance.  Company
        expects to earn $0.10 to $0.15 for all of 2003 before a potential
        one-time charge.

     -- Company reduces debt by an additional $15.7 million in October.

     -- Commercial business momentum continues with five theatre systems
        signings in third quarter and three additional signings since
        September.

TORONTO, Nov. 10 /PRNewswire-FirstCall/ -- IMAX Corporation (Nasdaq: IMAX; TSX: IMX) today reported net losses of $0.07 per share on a basic and fully diluted basis, including a gain of $0.01 from discontinued operations, for the quarter ended September 30, 2003. The results compare to net losses of $0.07 in the comparable period of 2002 and are consistent with guidance. Net losses from continuing operations were $0.08 per share on a basic and fully diluted basis for the third quarter ended September 30, 2003, as compared to losses from continuing operations of $0.13 per share for the three months ending September 30, 2002.

On November 5th, The Matrix Revolutions: The IMAX Experience, the first contemporaneous release of a live-action Hollywood event film in IMAX and 35mm theatres, set numerous one-day and weekend box office records, grossing over $3 million on 48 screens in North America, an average of almost $65,000 per screen, over its five-day opening. The international IMAX screens also performed exceptionally well, selling out the majority of shows while charging premiums of up to three times the ticket price at conventional theatres.

"The results from our first contemporaneous release are in, and we couldn't possibly be happier with the performance," said IMAX Co-Chief Executive Officers Richard L. Gelfond and Bradley J. Wechsler. "In many IMAX theatres the only limiting factor was running out of seats, with most of the IMAX network sold out for the majority of the weekend. We believe these results, which come on the heels of a highly successful IMAX release of The Matrix Reloaded, further solidify IMAX's place in the release strategy for Hollywood event films."

The Matrix Revolutions: The IMAX Experience is the most successful opening of an IMAX(R) DMR(TM) release to date. The North American per-screen revenue for the film's three-day weekend, at $37,000, was more than double that of The Matrix Reloaded: The IMAX Experience in its first weekend. Additionally, on just its opening day, The Matrix Revolutions: The IMAX Experience earned approximately $16,000 per screen selling out 6:00 a.m. shows across the west coast and charging an average adult ticket price of over $11.00, a premium of greater than $2.50 versus conventional theatres. Independent research performed over this initial period was also very positive, indicating that 87% of those polled who saw the film at an IMAX theatre would recommend seeing the film to others who had already seen it in a 35mm theatre.

In October, the Company retired an additional $15.7 million in outstanding senior notes through a series of debt-for-equity transactions, lowering the principal amount of its outstanding notes to $153 million. Separately, the Company announced that it plans to refinance all of its outstanding debt through an offering of new senior notes with a proposed maturity of 2010. The Company may take a charge to its earnings in the fourth quarter in relation to this proposed offering.

"We remain pleased with IMAX's financial results, which reflect the seasonality of our business and show a continued improvement over last year's performance," said Messrs. Gelfond and Wechsler. "We believe that many of the initiatives that IMAX is currently undertaking will be reflected in our financial results in 2004 and beyond, as our IMAX DMR technology and lower cost IMAX(R) MPX(TM) projection system begin to have an accelerating effect on new theatre signings." Messrs. Gelfond and Wechsler indicated that the Company expects to earn between $0.25 and $0.35 per share in 2004, approximately double the Company's expected 2003 earnings.

During the quarter, the Company signed new contracts for five IMAX theatre systems, including additional theatres to be opened by current IMAX customers in China and Moscow and a deal with Bella Films in Missouri, launching an initiative that may include future contracts for additional IMAX theatres. Subsequent to the end of the quarter, the Company singed deals for three additional systems, including a contract for two IMAX MPX theatres with a commercial property developer in Dubai, UAE.

During the first nine months of 2003, the Company signed contracts for 18 theatre systems as compared to 10 during the first nine months of 2002. Trailing 12-month IMAX theatre systems signings stand at 29, which is an increase of over 60% compared to 18 signings during the prior 12-month period.

In the third quarter, the Company's total revenues were $21.4 million as compared to $23.2 million in the prior year period. IMAX systems revenue was $11.5 million versus $9.6 million in the prior year period, as the Company recognized revenues on one theatre system in the third quarter of 2003, consistent with the one theatre system installed during the in the third quarter of 2002. Film revenue was $5.3 million versus $9.8 million in the third quarter of 2002, a decline primarily due to last year's release of the Company's record-breaking film SPACE STATION. Other revenue was $4.7 million in the quarter versus $3.8 million in the third quarter of 2002.

For the nine months ended September 30, 2003, the Company's revenues were $90.2 million as compared to $93.3 million in the prior-year period. Systems revenue was $55.9 million versus $50.7 million in the prior year period, as the Company recognized revenues on 15 theatre systems as compared to 11 theatre systems in the prior-year period. Films revenue was $19.6 million compared to $29.1 million. Other revenue was $14.7 million versus $13.6 million. For the nine months ended September 30, 2003, the company broke even in terms of net earnings per share from continuing operations on a fully diluted basis. During the first nine months of 2002, the Company earned $0.34 per share, which included a gain of $12 million from the repurchase of certain of the Company's subordinated notes.

The Company will be hosting a conference call to discuss these results at 10:30 AM EST. To access the call interested parties should call (719) 457-2727.

About IMAX Corporation:

Founded in 1967, IMAX Corporation is one of the world's leading entertainment technology companies. IMAX's businesses include the creation and delivery of the world's best cinematic presentations using proprietary IMAX and IMAX(R) 3D technology, and the development of the highest quality digital production and presentation. IMAX has developed revolutionary technology called IMAX DMR (Digital Re-mastering) that makes it possible for any 35mm film to be transformed into the unparalleled image and sound quality of The IMAX Experience(R). The IMAX brand is recognized throughout the world for extraordinary and immersive family experiences. As of September 30 2003, there were more than 235 IMAX theatres operating in 35 countries.

IMAX(R), IMAX(R) 3D, IMAX(R)DMR(TM) and The IMAX Experience(R) are trademarks of IMAX Corporation. More information on the Company can be found at www.imax.com.

This press release contains forward looking statements that are based on management assumptions and existing information and involve certain risks and uncertainties which could cause actual results to differ materially from future results expressed or implied by such forward looking statements. Important factors that could affect these statements include the timing of theatre system deliveries, the mix of theatre systems shipped, the timing of the recognition of revenues and expenses on film production and distribution agreements, the viability of new businesses and products, and fluctuations in foreign currency and in the large format and general commercial exhibition market. These factors and other risks and uncertainties are discussed in the Company's Annual Report on Form 10-K for the year ended December 31, 2002 and in the subsequent reports filed by the Company with the Securities and Exchange Commission.

                               IMAX CORPORATION
               CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
  In accordance with United States Generally Accepted Accounting Principles
           (in thousands of U.S. dollars, except per share amounts)
                                 (unaudited)


                                          Three months        Nine months
                                             ended               ended
                                          September 30,       September 30,
                                          2003     2002      2003      2002
    Revenue
    IMAX systems                        $11,455   $9,574   $55,913   $50,671
    Films                                 5,275    9,786    19,570    29,050
    Other                                 4,697    3,819    14,676    13,584
                                         21,427   23,179    90,159    93,305
    Costs of goods and services          12,081   16,397    51,075    54,427
    Gross margin                          9,346    6,782    39,084    38,878

    Selling, general and administrative
     expenses                             8,265    7,564    24,864    26,672
    Research and development                952      900     2,833     1,701
    Amortization of intangibles             181      339       473     1,067
    Income from equity-accounted
     investees                             (228)    (167)     (501)      (88)
    Receivable provisions, net of
     (recoveries)                          (425)  (1,173)      264        53
    Restructuring recoveries                 --     (497)       --      (497)
    Earnings (loss) from operations         601     (184)   11,151     9,970

    Interest income                         105      106       515       295
    Interest expense                     (3,606)  (4,299)  (11,949)  (13,048)
    Gain (loss) on retirement of notes     (146)      17      (333)   12,005
    Recovery on long-term investments       355       --       355        --
    Net earnings (loss) from continuing
     operations before income taxes      (2,691)  (4,360)     (261)    9,222

    Recovery of (provision for) income
     taxes                                 (163)      --       400        --
    Net earnings (loss) from continuing
     operations                          (2,854)  (4,360)      139     9,222
    Net earnings from discontinued
     operations                             200    2,066       599     2,066
    Net earnings (loss)                 $(2,654) $(2,294)     $738   $11,288

    Earnings (loss) per share:
    Earnings (loss) per share \_ basic
     and fully diluted:
        Net earnings (loss) from
         continuing operations           $(0.08)  $(0.13)    $  --     $0.28
        Net earnings from discontinued
         operations                       $0.01    $0.06     $0.02     $0.06
        Net earnings (loss)              $(0.07)  $(0.07)    $0.02     $0.34

    Weighted average number of shares
     outstanding (000's):
        Basic                            37,091   32,962    34,592    32,933
        Fully diluted                    37,091   32,962    35,124    33,263


                               IMAX CORPORATION
                    CONDENSED CONSOLIDATED BALANCE SHEETS
  In accordance with United States Generally Accepted Accounting Principles
                        (in thousands of U.S. dollars)

                                                   September 30,
                                                        2003     December 31,
                                                    (unaudited)      2002
    Assets
    Cash and cash equivalents                          $23,595    $37,136
    Accounts receivable, less allowance for doubtful
     accounts of $9,192 (2002 - $9,248)                 13,285     15,054

    Financing receivables                               53,914     51,918
    Inventories                                         29,012     34,092
    Prepaid expenses                                     2,999      2,383
    Film assets                                            580        419
    Fixed assets                                        40,242     45,308
    Other assets                                         8,801     10,455
    Deferred income taxes                                3,821      3,821
    Goodwill                                            39,027     39,027
    Other intangible assets                              3,765      3,363
            Total assets                              $219,041   $242,976

    Liabilities
    Accounts payable                                    $6,115     $6,768
    Accrued liabilities                                 44,824     43,451
    Deferred revenue                                    68,529     87,284
    Senior notes due 2005                              168,475    200,000
    Convertible subordinated notes due 2003                 --      9,143
            Total liabilities                          287,943    346,646

    Commitments and contingencies

    Shareholders' equity (deficit)
    Common stock \_ no par value.
     Authorized \_unlimited number
     Issued and outstanding
     \_ 37,353,298 (2002\_32,973,366)                     98,695     65,563
    Other equity                                         2,440      1,542
    Deficit                                           (170,682)  (171,420)
    Accumulated other comprehensive income                 645        645
            Total shareholders' equity (deficit)       (68,902)  (103,670)
            Total liabilities and shareholders' equity
             (deficit)                                 $219,041   $242,976

SOURCE IMAX Corporation

CONTACT:  
Media,  
Romi Schutzer of IMAX Corporation, New York  
+1-212-821-0144  
or  
rschutzer@imax.com  
or  
entertainment media  
Al Newman of Newman & Company, Los Angeles  
+1-818-784-2130  
or  
asn@newman-co.com  
or  
business media  
Whit Clay of Sloane & Company, New York  
+1-212-446-1864  
or  
wclay@sloanepr.com  
or  
analysts  
Jennifer Gery of IMAX Corporation, New York  
+1-212-821-0144  
or  
jgery@imax.com  
Company News On-Call: http://www.prnewswire.com/comp/103201.html  
Web site: http://www.imax.com  
(IMAX)